These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21628312)

  • 1. Increasing B-type natriuretic peptide levels predict mortality in unselected haemodialysis patients.
    Breidthardt T; Kalbermatter S; Socrates T; Noveanu M; Klima T; Mebazaa A; Mueller C; Kiss D
    Eur J Heart Fail; 2011 Aug; 13(8):860-7. PubMed ID: 21628312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
    Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
    Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients.
    Chazot C; Vo-Van C; Zaoui E; Vanel T; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Jean G
    Nephrol Dial Transplant; 2011 Aug; 26(8):2630-4. PubMed ID: 21273234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of B-type natriuretic peptide from baseline increases the risk of death or retransplant in pediatric cardiac transplant patients, midterm results.
    Bramlet M; Moore R; Murphy D; Caldwell R; Darragh R; Schamberger M
    Congenit Heart Dis; 2010; 5(3):297-302. PubMed ID: 20576050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux hemodialysis and hemodiafiltration.
    Sivalingam M; Suresh M; Farrington K
    Hemodial Int; 2011 Jul; 15(3):359-65. PubMed ID: 21624043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic potential of brain natriuretic peptide (BNP) in predialysis chronic kidney disease patients.
    Carr SJ; Bavanandan S; Fentum B; Ng L
    Clin Sci (Lond); 2005 Jul; 109(1):75-82. PubMed ID: 15743271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C; Beimler J; Schwenger V; Heckele N; Katus HA; Giannitsis E; Zeier M
    Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma B-type natriuretic peptide level predicts kidney prognosis in patients with predialysis chronic kidney disease.
    Yasuda K; Kimura T; Sasaki K; Obi Y; Iio K; Yamato M; Rakugi H; Isaka Y; Hayashi T
    Nephrol Dial Transplant; 2012 Oct; 27(10):3885-91. PubMed ID: 23114906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients.
    Toussaint ND; Polkinghorne KR; Kerr PG
    Hemodial Int; 2008 Apr; 12(2):254-63. PubMed ID: 18394060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
    N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.
    Goei D; van Kuijk JP; Flu WJ; Hoeks SE; Chonchol M; Verhagen HJ; Bax JJ; Poldermans D
    Am J Cardiol; 2011 Feb; 107(4):609-14. PubMed ID: 21185000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis.
    Pimenta J; Paulo C; Gomes A; Silva S; Rocha-Gonçalves F; Bettencourt P
    Liver Int; 2010 Aug; 30(7):1059-66. PubMed ID: 20492497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
    Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
    Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea.
    Christ M; Thuerlimann A; Laule K; Klima T; Hochholzer W; Perruchoud AP; Mueller C
    Eur J Clin Invest; 2007 Nov; 37(11):834-41. PubMed ID: 17931382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].
    Bertinchant JP
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):881-8. PubMed ID: 15521481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.
    Ryding AD; Kumar S; Worthington AM; Burgess D
    Anesthesiology; 2009 Aug; 111(2):311-9. PubMed ID: 19602961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.